<DOC>
	<DOC>NCT01486888</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to to test for bioequivalence between two formulations of Mixtard® 30 in healthy subjects.</brief_summary>
	<brief_title>Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin, pork; isophane insulin, pork drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Considered generally healthy upon completion of medical history and physical examination as judged by the Investigator Body Mass Index (BMI) between 18.0 and 27.0 kg/m^2, inclusive Nonsmoker, defined as no nicotine consumption for at least one year Fasting plasma glucose below or equal to 100 mg/dL (5.6 mmol/L) Previous participation in this trial or other clinical trials within the last 3 months Body weight above 87.5 kg Pregnant, breastfeeding or the intention of becoming pregnant or not using adequate contraceptive measures (intrauterine device (IUD) that has been in place for at least 3 History of alcohol or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>